Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suvorexant for Post-surgical Insomnia
NCT05823844Phase 4Completed
- Sponsor
- Columbia University
- Start
- May 2023
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of suvorexant in insomnia after surgery, postoperative delirium (POD), sponsored by Columbia University. Started May 2023; status: completed.
02
Drugs
suvorexant
03
Conditions
insomnia after surgerypostoperative delirium (POD)
Beyond the preview
Go deeper on NCT05823844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05823844.